Skip to main content
. 2018 Nov 6;133(1):40–50. doi: 10.1182/blood-2018-06-856500

Table 3.

Potential role of hepcidin in the diagnosis and management of anemia

Condition Expected hepcidin levels Iron variables Iron therapy strategies Potential hepcidin therapy
Absolute IDA Low Low Tsat and ferritin PO (or IV if PO poorly tolerated or malabsorbed) No
Functional iron deficiency (ESA therapy, CKD) Variable, depending on the severity and etiology of CKD Low Tsat, variable ferritin IV or oral if low disease activity Antagonist (if hepcidin levels not low)
Iron sequestration (AI) High Low Tsat, normal to elevated ferritin IV Antagonist
Mixed anemia (AI/IDA or AI/functional iron deficiency) Variable Low Tsat, low to normal ferritin IV or oral if low disease activity Antagonist (if hepcidin levels not low)
Iron-loading anemias (eg, ineffective erythropoiesis) Low High Tsat and ferritin Iron chelation therapy Agonist
Iron-loading anemias treated with transfusion Normal to high High Tsat and ferritin Iron chelation therapy Agonist

CKD, chronic kidney disease; PO, by mouth; Tsat, transferrin saturation.